Aetiology, ejection fraction and mortality in chronic heart failure: a mediation analysis

Josef Fritz1, Katrin Belovari2, Hanno Ulmer1

  • 1Institute of Medical Statistics and Informatics, Medical University of Innsbruck, Innsbruck, Austria.

PubMed

Insights

The cause of chronic heart failure (CHF) significantly impacts mortality, with direct effects outweighing those mediated by left ventricular ejection fraction (LVEF). Identifying the specific etiology is crucial for patient outcomes.

Area of Science:

  • Cardiology
  • Clinical Research
  • Heart Failure Management

Background:

  • Clinical decision-making in chronic heart failure (CHF) primarily relies on left ventricular ejection fraction (LVEF).
  • The underlying etiology of CHF is considered secondary in current treatment strategies.
  • Understanding the interplay between etiology, LVEF, and mortality is essential for optimizing patient care.

Purpose of the Study:

  • To investigate the mediating role of LVEF in the relationship between CHF etiology and patient mortality.
  • To quantify the direct and indirect effects of various CHF etiologies on overall mortality.
  • To determine the relative importance of etiology versus LVEF in predicting mortality.

Main Methods:

  • Analysis of data from 2056 Austrian CHF patients with a mean follow-up of 8.8 years.
  • Utilized multivariable-adjusted linear and Cox regression models to assess effects of etiology on LVEF and mortality.
  • Employed causal mediation analyses to decompose the total effect of etiology on mortality into direct and indirect pathways through LVEF.

Main Results:

  • The effect of LVEF on mortality was consistent across analyzed etiologies (e.g., dilated cardiomyopathy, hypertrophic cardiomyopathy, ischemic heart disease, hypertensive heart disease, cardiac amyloidosis).
  • Cardiac amyloidosis (CA) showed the highest mortality, with a significant indirect effect mediated through LVEF.
  • For most etiologies, less than 20% of the total mortality effect was mediated through LVEF, indicating a dominant direct effect of etiology.

Conclusions:

  • The direct impact of CHF etiology on mortality is more significant than the indirect effect mediated by LVEF.
  • Clarifying the specific etiology of chronic heart failure is as critical as measuring LVEF for accurate prognosis.
  • These findings underscore the need to integrate etiological assessment into clinical decision-making for CHF patients.
Abstract

Keywords:
heart failure

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
460
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
14